Table 1.
Peripheral neuropathy according to NCI-CTC Version 4.0
Adverse event | Grade
|
||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Peripheral motor neuropathy | Asymptomatic, clinical or diagnostic observations only, intervention not indicated | Moderate symptoms, limiting instrumental ADL | Severe symptoms, limiting self-care ADL, assistive device indicated | Life-threatening consequences, urgent intervention indicated | Death |
Peripheral sensory neuropathy | Asymptomatic, loss of deep tendon reflexes or paresthesia | Moderate symptoms, limiting instrumental ADL | Severe symptoms, limiting self-care ADL | Life-threatening consequences, urgent intervention indicated | Death |
Neuralgia | Mild pain | Moderate pain, limiting instrumental ADL | Severe pain, limiting self-care ADL | – | – |
Note: Data from National Cancer Institute.7
Abbreviations: NCI-CTC, National Cancer Institute – Common Toxicity Criteria; ADL, activities of daily living.